Avicanna Completes Registration and Commercial Export of its Evidence-Based CBD Dermacosmetics Brand, Pura Earth, in Ecuador
Retrieved on:
Thursday, September 16, 2021
Pura, Cream, Aureus, IR, B, Itch, Absorption, Skin, Patient, Tea tree oil, Skin care, Solution, Ageing, Committee on Herbal Medicinal Products, Cannabinoid, Atopic dermatitis, Research, Risk, Science, OA, Comparison, GMP, Exocrine gland, MaRS Discovery District, Erythema, CBG, Article, GLOBE, Committee, NOT, Chronic pain, Cell, Dermatology, Prospectus, FSE, Rosemary, THC, Tea tree, Perception, FOR, Benzoyl peroxide, Control, Acne, Carson, Safety, Dermatitis, Disorder, TSX, Control-Y, European Medicines Agency, Stock, RHO, SEDAR, Animal, Company, ARCSA, Journal of Medicinal Food, Industry, Review, Medical Journal of Australia, Lists of diseases, Molecule, Partnership, Riley, Journal, News, Pharmaceutical industry, Fine chemical, Cosmetics, Dietary supplement, Silviculture
TORONTO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that it has completed product registration and its first commercial export of its Pura Earth branded dermacosmetics products in Ecuador.
Key Points:
- In addition to the completed clinical trials all Pura Earth products are not tested on animals and are vegan.
- The 3 cosmetic clinical studies were completed on Avicannas formulations targeting cosmetic factors associated with aging, acne-prone skin, and eczema-prone skin.
- Intersive Moisturizing Cream: Oil-based formula uniquely marries CBD, colloidal oatmeal and hemp seed oil aimed at relieving skin redness 2,10.
- Pura H&W/Pura Earth: these registered, clinically tested, cosmetic products include a portfolio of functional CBD consumer derma-cosmetic and topical products.